Cargando…

Development of a chronic kidney disease patient navigator program

BACKGROUND: Chronic Kidney Disease (CKD) is a public health problem and there is a scarcity of type 2 CKD translational research that incorporates educational tools. Patient navigators have been shown to be effective at reducing disparities and improving outcomes in the oncology field. We describe t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jolly, Stacey E, Navaneethan, Sankar D, Schold, Jesse D, Arrigain, Susana, Konig, Victoria, Burrucker, Yvette K, Hyland, Jennifer, Dann, Priscilla, Tucky, Barbara H, Sharp, John W, Nally, Joseph V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459709/ https://www.ncbi.nlm.nih.gov/pubmed/26024966 http://dx.doi.org/10.1186/s12882-015-0060-2

Ejemplares similares

Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease
por: Patel, Krishna K., et al.
Publicado: (2019)

Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999–2004
por: Navaneethan, Sankar D, et al.
Publicado: (2014)

Electronic health records: a new tool to combat chronic kidney disease?
por: Navaneethan, Sankar D., et al.
Publicado: (2013)

Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006
por: Navaneethan, Sankar D., et al.
Publicado: (2012)

Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
por: Hassanein, Mohamed, et al.
Publicado: (2022)

Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020)

Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020)

Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
por: Cholin, Liza, et al.
Publicado: (2021)

Urine Sediment Examination: Comparison Between Laboratory-Performed Versus Nephrologist-Performed Microscopy and Accuracy in Predicting Pathologic Diagnosis in Patients with Acute Kidney Injury
por: Fadel, Remy, et al.
Publicado: (2023)

Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease
por: Navaneethan, Sankar D., et al.
Publicado: (2017)

“What do you think about nephrology?” A national survey of internal medicine residents
por: Nakhoul, Georges N., et al.
Publicado: (2021)

Bariatric Surgery and Kidney-Related Outcomes
por: Chang, Alex R., et al.
Publicado: (2017)

A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease
por: Navaneethan, Sankar D, et al.
Publicado: (2008)

Management of type 2 diabetes in chronic kidney disease
por: Triozzi, Jefferson L, et al.
Publicado: (2021)

Geographic hot spots of kidney transplant candidates wait‐listed post‐dialysis
por: Buchalter, R. Blake, et al.
Publicado: (2022)

Statins in Patients with Chronic Kidney Disease: Evidence from Systematic Reviews and Randomized Clinical Trials
por: Navaneethan, Sankar D, et al.
Publicado: (2006)

Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate
por: Walther, Carl P., et al.
Publicado: (2022)

Deceased Donor Kidneys Utilization and Discard Rates During COVID-19 Pandemic in the United States
por: Li, Miah T., et al.
Publicado: (2021)

Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study
por: Taliercio, Jonathan J., et al.
Publicado: (2022)

Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant
por: Husain, S. Ali, et al.
Publicado: (2021)

Omega‐3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk
por: Navaneethan, Sankar D., et al.
Publicado: (2017)

Defining a minimal clinically meaningful difference in 12‐month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation
por: Mayne, Tracy J., et al.
Publicado: (2021)

Characterization of Transplant Center Decisions to Allocate Kidneys to Candidates With Lower Waiting List Priority
por: King, Kristen L., et al.
Publicado: (2023)

Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes
por: Airy, Medha, et al.
Publicado: (2019)

Population Characteristics and Organ Procurement Organization Performance Metrics
por: Lopez, Rocio, et al.
Publicado: (2023)

Long-term Outcome Reporting in Older Kidney Transplant Recipients and the Limitations of Conventional Survival Metrics
por: Vanhove, Thomas, et al.
Publicado: (2022)

Hospital procedure volume does not predict acute kidney injury after coronary artery bypass grafting—a nationwide study
por: Sakhuja, Ankit, et al.
Publicado: (2017)

Untangling the Clinical and Methodological Assessment of Risks Associated With BK Nephropathy
por: Stites, Erik, et al.
Publicado: (2023)

Contribution of Estimates of Glomerular Filtration to the Extensive Disparities in Preemptive Listing for Kidney Transplant
por: King, Kristen L., et al.
Publicado: (2022)

Pseudo-anion gap acidosis
por: Navaneethan, Sankar D., et al.
Publicado: (2008)

Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease
por: Malin, Steven K., et al.
Publicado: (2020)

Statin use and hip fractures in U.S. kidney transplant recipients
por: Vangala, Chandan, et al.
Publicado: (2017)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2014)

Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary Care
por: Joshi, Priya, et al.
Publicado: (2022)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2015)

Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021)

Improvement of endothelial function following initiation of testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)

Navigating to health: Evaluation of a community health center patient navigation program
por: Wang, Monica L., et al.
Publicado: (2015)

Experiences with a patient-oriented navigation program in Germany from the navigators' perspectives
por: Fuegemann, H, et al.
Publicado: (2023)

Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States
por: Schold, Jesse D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rmroft8v9ttjli5vdsr3tuc2b